Personalized medicine. Part 3: Challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testing

P and T

Volumn 35, Issue 12, 2010, Pages 670-675

  Vogenberg, F Randy ^a,b,c   Barash, Carol Isaacson ^d   Pursel, Michael ^e  

^a Institute for Integrated Healthcare   (United States)

^b JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d Genetics Ethics and Policy Consulting Inc   (United States)

^e NONE

Author keywords

Diagnostic pipeline; Drug pipeline; Manufacturer pipeline; Medical device pipeline; Medication coverage and underwriting; Personalized medicine; Pharmacogenomics

Indexed keywords

COST EFFECTIVENESS ANALYSIS; GENETIC SCREENING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH INSURANCE; MEDICAL GENETICS; PHARMACOGENOMICS; REIMBURSEMENT; REVIEW;

EID: 78650192731     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Maas A. An interview with Per Lofberg. Specialty Pharmacy News, November 10, 2009.
2. Maas A. As genetic testing picks up steam, PBMs boost their capabilities. Specialty Pharmacy News, May 18, 2010.
3. Frojo R. Medco, CVS Caremark gear up to expand genetic testing management services. Drug Benefit News, June 7, 2010.
4. Scientia Advisors, Cambridge, Mass. Available at: www.scientiaadv. com/Sustainable-Growth-For-POC-Testing-PR-09-10.php. Accessed November 8, 2010.
5. Steenhuysen J. Gene test users largely satisfied, survey finds. Reuters, November 5, 2010. Available at: www.reuters.com/article/idustre6A45K820101105.
6. Wrick KL. Direct-to-Consumer Genetic Testing: Business Prospects in the United States. Needham, Mass.: Cambridge Healthtech Institute, Insight Pharma Reports. Available at: www.insight pharmareports.com/reports-report.aspx?id= 88534&r=640.Accessed November 8, 2010.
7. Pricewaterhouse Coopers. Personalized Medicine. Available at: www.pwc.com/us/en/health-industries/topics/personalized-medicine.jhtml. Accessed March 8, 2010.
8. Health Business Outlook 2010 newsletter. Washington, D.C.: Atlantic Information Services, Inc.; pp. 12-15. Available at: www.ais.com. Accessed November 8, 2010.
9. DMAA requests moratorium on GINA's 'underwriting' restrictions: Personalized Rx advocates object, December 2, 2009. Available at: www.genomeweb.com/dxpgx/dmaa-requests-moratorium-ginas-underwriting- restrictions-personalized-rxadvocat. Accessed May 31, 2010.
10. Mancinelli L, Cronin M, Sadee W. Pharmacogenomics: The Promise of Personalized Medicine. AAPS Pharm Sci 2000;(1): Article 4. Available at: www.aapsj.org/view.asp?art=ps020104. Accessed November 8, 2010.